Fabio Luciani

Fabio Luciani

Professor of Systems Immunology, Immunogenomics and Artificial Intelligence

University of New South Wales

Vision of our Lab

Welcome to our multi-disciplinary lab, where we integrate immunology, bioinformatics, AI, and genomics to advance our understanding of autoimmune disorders and cancer. Our vision is to develop a precise cure for autoimmune diseases and cancers, by integrating computational models, artificial intelligence and immunogenomics.

Research Focus

Our lab investigates T cell responses across various contexts:

  • Autoimmune diseases: Coeliac disease, Type 1 diabetes
  • Immunotherapies: CAR T cell therapies, Immuno-checkpoint
  • Ageing

Technologies

To achieve our goals, we utilize:

  • Artificial intelligence to predict immune target
  • Single-cell genomics
  • Bioinformatics
  • Experimental immunology

We invite PhD and Postdocs to join us, engaging in both ‘wet’ (laboratory) and ‘dry’ (computational) projects. PhD Scholarships are available for international candidates, and Summer Research Scholarships for third-year undergraduates.

Meet the Team

Team Leader

Avatar

Fabio Luciani

Professor of Systems Immunology, Immunogenomics and Artificial Intelligence

Team Members

Avatar

Arman Safavi

PhD student Systems Immunology and Immunogenomics

Avatar

Brendan Hughes

PhD student Systems Immunology and Immunogenomics

Avatar

Jerome Samir

Post-Doc at Systems Immunology and Immunogenomics

Avatar

Martina Bonomi

PhD student Systems Immunology and Immunogenomics

Alumni

  • Simone Rizzetto, now Data Analyst at A-Star Insititute Singapore
  • Raymond Louie, now Lecturer at UNSW
  • David Koppstein, now Group leader at DKTK Heidelberg
  • Lies Boelen, now Senior Data Analyst
  • Preston Leung, Senior postdoc in genomics at Prince of Wales hospital
  • Thiruni Adikari, now postdoc at Oxford
  • Curtis Cai, now postdoc at Karolinska Institutet
  • Chaturaka Rodrigo, now Senior Lecturer at UNSW
  • Neil Bretana, now Data Analyst at University of South Australia

Projects

Publications

Quickly discover relevant content by filtering publications.

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

Peripheral CD8+ T cell tolerance is a checkpoint in both autoimmune disease and anti-cancer immunity. Despite its importance, the …

Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection

Heterogeneity of T cells is a hallmark of a successful adaptive immune response, harnessing the vast diversity of antigen-specific T …

Expanded T cell clones with lymphoma driver somatic mutations in refractory celiac disease

Intestinal inflammation continues in a subset of celiac disease (CD) patients despite a gluten-free diet. Here, by applying multiomic …

CAR+ and CAR− T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies

Chimeric antigen receptor (CAR) T cell therapy is effective in treating B cell malignancies, but factors influencing the persistence of …

Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance

Epithelial cell adhesion molecule (EpCAM) is a tumor-associated antigen that is frequently overexpressed in various carcinomas. We have …

News and Updates

Contacts

  • High Street, Kensington Campus, Sydney, NSW 2035